Talc mediates angiostasis in malignant pleural effusions via endostatin induction

Najmunnisa N., Mohammed K. A., Brown S., Su Y., Sriram P. S., Moudgil B., Loddenkemper R., Antony V. B.

Source: Eur Respir J 2007; 29: 761-769

Journal Issue: April

Disease area: Thoracic oncology

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Najmunnisa N., Mohammed K. A., Brown S., Su Y., Sriram P. S., Moudgil B., Loddenkemper R., Antony V. B.. Talc mediates angiostasis in malignant pleural effusions via endostatin induction. Eur Respir J 2007; 29: 761-769

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Malignant pleural effusions Source: ISSN=1025-448x, ISBN=1-904097-25-1, page=177 Year: 2002
Talc pleurodesis in malignant pleural effusions Source: Eur Respir J 2001; 18: Suppl. 33, 386s Year: 2001
Transudative malignant pleural effusions Source: International Congress 2019 – Novel approaches to pleural effusion: should I change my practice? Year: 2019
Videothoracoscopy in the treatment of malignant pleural effusions Source: Annual Congress 2009 - Pleural and mediastinal diseases Year: 2009
Pleurodesis for malignant pleural effusion Source: School Course 2014 - Medical Thoracoscopy Year: 2014
Pleurodesis for malignant pleural effusion Source: ERS Course 2016 - Skills course on medical thoracoscopy Year: 2016
Malignant pleural disease in primary lung cancer Source: Eur Respir Mon; 2009: 44: 318–335 Year: 2009
Intrapleural fibrinolysis modulation in malignant pleural effusions Source: Eur Respir J 2001; 18: Suppl. 33, 517s Year: 2001
Clinical role of pleural effusion MMP-3 levels in malignant pleural mesothelioma Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions Year: 2012
Pleurodesis in the treatment of malignant pleural effusion Source: Eur Respir J 2004; 24: Suppl. 48, 628s Year: 2004
Efficacious pleurodesis with OK-432 and doxorubicin against malignant pleural effusions Source: Eur Respir J 2004; 24: 263-266 Year: 2004
Management of malignant pleural effusions Source: Eur Respir J 2001; 18: 402-419 Year: 2001
Management of malignant pleural effusions Source: Guideline 2001 Year: 2001
Management of malignant pleural effusions Source: ERS Skills course: Multi-disciplinary care in thoracic oncology Year: 2019
The value of IL6 in differentiation between malignant and non malignant pleural effusion Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience Year: 2009
Pleurodesis of malignant pleural effusion with OK432 Source: Eur Respir J 2003; 22: Suppl. 45, 61s Year: 2003
Osteopontin is important for malignant pleural effusion formation Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease? Year: 2009
Comparison in effectiveness and proinflammatory mediators between talc, doxycycline and tetracycline for pleurodesis in malignant pleural effusions (MPE) Source: Annual Congress 2006 - New developments in diagnostic and therapeutic bronchoscopy and thoracoscopy Year: 2006